Mustang Bio, Inc. Stock News
$1.65
0.00%
yesterday
Nasdaq,
Oct 15, 10:16 pm CET
Mustang Bio, Inc. Stock News
Positive
Finbold
●
3 months ago
Shares of Mustang Bio (NASDAQ: MBIO) surged on Monday as investors responded to a significant approval from the Food and Drug Administration (FDA).
Neutral
GlobeNewsWire
●
3 months ago
In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+ months, respectively
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
